ENTA Enanta Pharmaceuticals Inc

USD 16.53 0.58 3.636364
Icon

Enanta Pharmaceuticals Inc (ENTA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 16.53

+0.58 (+3.64)%

USD 0.31B

0.48M

USD 24.17(+46.20%)

USD 36.00 (+117.79%)

Icon

ENTA

Enanta Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 16.53
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 0.31B

USD 36.00 (+117.79%)

USD 16.53

Enanta Pharmaceuticals Inc (ENTA) Stock Forecast

Show ratings and price targets of :
USD 24.17
(+46.20%)

Based on the Enanta Pharmaceuticals Inc stock forecast from 4 analysts, the average analyst target price for Enanta Pharmaceuticals Inc is USD 24.17 over the next 12 months. Enanta Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Enanta Pharmaceuticals Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Enanta Pharmaceuticals Inc’s stock price was USD 16.53. Enanta Pharmaceuticals Inc’s stock price has changed by +14.00% over the past week, +17.65% over the past month and -58.49% over the last year.

No recent analyst target price found for Enanta Pharmaceuticals Inc
No recent average analyst rating found for Enanta Pharmaceuticals Inc

Company Overview Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection wi...Read More

https://www.enanta.com

500 Arsenal Street, Watertown, MA, United States, 02472

145

September

USD

USA

Adjusted Closing Price for Enanta Pharmaceuticals Inc (ENTA)

Loading...

Unadjusted Closing Price for Enanta Pharmaceuticals Inc (ENTA)

Loading...

Share Trading Volume for Enanta Pharmaceuticals Inc Shares

Loading...

Compare Performance of Enanta Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ENTA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Enanta Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing ENTA

Symbol Name ENTA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Enanta Pharmaceuticals Inc (ENTA) Stock

Based on ratings from 4 analysts Enanta Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 4 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on ENTA's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for ENTA is USD 24.17 over the next 12 months. The maximum analyst target price is USD 30 while the minimum anlayst target price is USD 15.

ENTA stock's Price/Earning ratio is 436.70. Our analysis grades ENTA stock's Price / Earning ratio at F. This means that ENTA stock's Price/Earning ratio is above 96% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ENTA may be a overvalued for its sector.

The last closing price of ENTA's stock was USD 16.53.

The most recent market capitalization for ENTA is USD 0.31B.

Based on targets from 4 analysts, the average taret price for ENTA is projected at USD 24.17 over the next 12 months. This means that ENTA's stock price may go up by +46.20% over the next 12 months.

We can't find any ETFs which contains Enanta Pharmaceuticals Inc's stock.

As per our most recent records Enanta Pharmaceuticals Inc has 145 Employees.

Enanta Pharmaceuticals Inc's registered address is 500 Arsenal Street, Watertown, MA, United States, 02472. You can get more information about it from Enanta Pharmaceuticals Inc's website at https://www.enanta.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...